SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-034653
Filing Date
2018-06-01
Accepted
2018-06-01 16:13:36
Documents
1
Period of Report
2018-05-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3871
  Complete submission text file 0001209191-18-034653.txt   5286
Mailing Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472
Business Address 480 ARSENAL STREET SUITE 110 WATERTOWN MA 02472 617.715.3600
TETRAPHASE PHARMACEUTICALS INC (Issuer) CIK: 0001373707 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TETRAPHASE PHARMACEUTICALS, INC. 480 ARSENAL ST., SUITE 101 WATERTOWN MA 02472
Business Address
Chodakewitz Jeffrey (Reporting) CIK: 0001610876 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35837 | Film No.: 18875215